2,277
Views
14
CrossRef citations to date
0
Altmetric
Editorial

Costing bias in economic evaluations

, , &
Pages 596-599 | Accepted 20 Mar 2015, Published online: 09 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Paul C. Langley. (2015) Validation of modeled pharmacoeconomic claims in formulary submissions. Journal of Medical Economics 18:12, pages 993-999.
Read now

Articles from other publishers (13)

Laura Mirjami Jolma, Mikko Koivu-Jolma, Anne Sarajuuri, Paulus Torkki, Ilona Autti-Rämö & Heli Sätilä. (2023) Children with FASD—Evolving Patterns of Developmental Problems and Intervention Costs in Ages 0 through 16 in Finland. Children 10:5, pages 788.
Crossref
Claudia Fischer, Susanne Mayer, Nataša Perić & Judit Simon. (2022) Harmonization issues in unit costing of service use for multi-country, multi-sectoral health economic evaluations: a scoping review. Health Economics Review 12:1.
Crossref
Susanne Mayer, Michael Berger, Alexander Konnopka, Valentin Brodszky, Silvia M. A. A. Evers, Leona Hakkaart-van Roijen, Mencia R. Guitérrez-Colosia, Luis Salvador-Carulla, A-La Park, William Hollingworth, Lidia García-Pérez & Judit Simon. (2022) In Search for Comparability: The PECUNIA Reference Unit Costs for Health and Social Care Services in Europe. International Journal of Environmental Research and Public Health 19:6, pages 3500.
Crossref
Claudia Fischer, Susanne Mayer, Nataša Perić & Judit Simon. (2022) Establishing a comprehensive list of mental health-related services and resource use items in Austria: A national-level, cross-sectoral country report for the PECUNIA project. PLOS ONE 17:1, pages e0262091.
Crossref
Veronique Lambert-Obry, Jean-Philippe Lafrance, Michelle Savoie & Jean Lachaine. (2022) Real-world evidence: a practical toolbox for collecting health state utilities. Journal of Comparative Effectiveness Research 11:1, pages 57-64.
Crossref
Samira B. Jabakhanji, Jan Sorensen, Gintare Valentelyte, Lee Ann Burke, Brendan McElroy & Aileen Murphy. (2021) Assessing direct healthcare costs when restricted to self-reported data: a scoping review. Health Economics Review 11:1.
Crossref
Rafael J. Vargas Alves, Ana P. Beck da Silva Etges, Katsuki Arima Tiscoski, Luciana Rodrigues de Lara, Alice de Medeiros Zelmanowicz & Carisi Anne Polanczyk. (2021) The cost of metastatic prostate cancer using time-driven activity-based costing. International Journal of Technology Assessment in Health Care 37:1.
Crossref
László Lorenzovici, Andrea Székely, Marcell Csanádi & Péter Gaál. (2020) Cost Assessment of Inpatient Care Episodes of Stroke in Romania. Frontiers in Public Health 8.
Crossref
Allison Portnoy, Kelsey Vaughan, Emma Clarke-Deelder, Christian Suharlim, Stephen C. Resch, Logan Brenzel & Nicolas A. Menzies. (2020) Producing Standardized Country-Level Immunization Delivery Unit Cost Estimates. PharmacoEconomics 38:9, pages 995-1005.
Crossref
Patrick Fahr, James Buchanan & Sarah Wordsworth. (2019) A Review of Health Economic Studies Comparing Traditional and Massively Parallel Sequencing Diagnostic Pathways for Suspected Genetic Disorders. PharmacoEconomics 38:2, pages 143-158.
Crossref
Madeleine M. Blank, Lilian Chen, Marianna Papageorge, Daniel Driscoll, Roger Graham & Abhishek Chatterjee. (2018) The underreporting of cost perspective in cost-analysis research: A systematic review of the plastic surgery literature. Journal of Plastic, Reconstructive & Aesthetic Surgery 71:3, pages 366-376.
Crossref
Roslyn Prichard, Louise Kershaw, Patricia M. Davidson, Phillip J. Newton, Stephen Goodall & Christopher Hayward. (2018) COMBINING INSTITUTIONAL AND ADMINISTRATIVE DATA TO ASSESS HOSPITAL COSTS FOR PATIENTS RECEIVING VENTRICULAR ASSIST DEVICES. International Journal of Technology Assessment in Health Care 34:6, pages 555-566.
Crossref
Hanna Gyllensten, Anna K. Jönsson, Katja M. Hakkarainen, Staffan Svensson, Staffan Hägg & Clas Rehnberg. (2017) Comparing Methods for Estimating Direct Costs of Adverse Drug Events. Value in Health 20:10, pages 1299-1310.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.